Yes, imo.
I'm a big fan of Elixinol, but the low daily volume itself, among other factors, shows that the company needs much more media exposure.
The last time I checked, there were no professional institutional investors/funds, etc. That needs to change.
Again, I'm a big fan of the company, but it remains a secret in the larger investing world. Plans to uplist to NYSE or NASDAQ would be hge.